Solumiks

Ayurvedic healthcare formulations and exports in India.

About Solumiks

Solumiks is a Healthcare company. Ayurvedic healthcare formulations and exports in India. The company has 68 employees. Its Indian entity Solumiks Herbaceuticals Limited reported revenue of β‚Ή17.01 Cr. Solumiks offers products and services including Myostaal and Pyroflex. Its focus areas include Pharmaceuticals, Ayurvedic Medicine, Herbal Formulations and Exports.

Company details

Solumiks is recognized as a company that has been dedicated to healthcare for over 45 years, with Ayurvedic products being presented through the integration of modern science. These formulations, including Myostaal and Pyroflex, have been patronized by medical practitioners in India and abroad, aiding the consolidation of its position in the sector. Efforts are made to achieve higher levels of quality and customer satisfaction through standardized and effective practices, while ethical business approaches are followed in spreading scientific Ayurvedic therapeutics globally.

Key Metrics
  • Indian entity revenue
    ₹17.01 Cr

    FY 2026 · +1% YoY

  • Indian entity net loss
    -₹1.64 Cr

    FY 2026 · -10% margin

  • Indian entity EBITDA
    -₹1.69 Cr

    FY 2026 · -10% margin

  • Employee Count
    68

Products & Services of Solumiks

Solumiks offers a comprehensive portfolio of products and services, including Myostaal and Pyroflex.

Myostaal
Ayurvedic Products

An Ayurvedic formulation is provided for healthcare needs.

Pyroflex
Ayurvedic Products

Another Ayurvedic product is offered for specific health purposes.

Board of directors of Solumiks Herbaceuticals Limited (Solumiks)

Solumiks Herbaceuticals Limited is the primary company behind Solumiks. The board of Solumiks Herbaceuticals Limited currently have 3 directors; the longest-serving is Suvarna Ranjit Puranik, appointed in 2005. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Suvarna Ranjit Puranik
DIN 00199390
Director21 Jul 200521 yrs 3 moSolumiks Herbaceuticals Limited
Nutan Rajan Patankar
DIN 00943853
Director20 Nov 200619 yrs 11 moSolumiks Herbaceuticals Limited
Ranjit Anand Puranik
DIN 00199353
Director29 Mar 20242 yrs 7 moSolumiks Herbaceuticals Limited

Financials of Solumiks

Figures of Solumiks Herbaceuticals Limited, the primary company behind Solumiks, for FY 2026. Revenue was ₹17.01 Cr (+1% year on year). Net loss was -₹1.64 Cr (-10% margin). EBITDA was -₹1.69 Cr (-10% margin). Revenue has grown at a compounded annual rate of +7% over three years and +4% over five years.

  • ₹17.01 CrRevenue · FY 2026 · +1% YoY
  • -₹1.64 CrNet loss · -10% margin
  • -₹1.69 CrEBITDA · -10% margin
  • ₹40 LakhPaid-up capital
  • 111Employees (provident fund records)
  • +7%Revenue CAGR, 3 years
  • +4%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Solumiks Herbaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Solumiks

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Solumiks

Solumiks has 68 employees.

The primary company behind Solumiks, Solumiks Herbaceuticals Limited, reported revenue of β‚Ή17.01 Cr for FY 2026, up 1% year on year.

Solumiks is recognized as a company that has been dedicated to healthcare for over 45 years, with Ayurvedic products being presented through the integration of modern science. These formulations, including Myostaal and Pyroflex, have been patronized by medical practitioners in India and abroad, aiding the consolidation of its position in the sector. Efforts are made to achieve higher levels of quality and customer satisfaction through standardized and effective practices, while ethical business approaches are followed in spreading scientific Ayurvedic therapeutics globally.

Solumiks offers Myostaal and Pyroflex.

Solumiks operates through Solumiks Herbaceuticals Limited.

The legal entities of Solumiks currently have 3 directors, including Ranjit Anand Puranik, Suvarna Ranjit Puranik, Nutan Rajan Patankar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available